Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans L Tillmann

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Journal of Hepatology|October 16, 2012
IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patientsMelanie E Garrett, Manal F Abdelmalek, Allison Ashley-Koch, et al.
Antiviral Therapy|December 14, 2011
Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patientsKeyur Patel, Seng G Lim, Chow W Cheng, et al.
Gastroenterology|February 24, 2010
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirinJeanette J McCarthy, Josephine H Li, Alexander Thompson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trialHans L Tillmann, Thorsten Kaiser, Zoe Fox, et al.
Journal of Medicinal Chemistry|August 20, 2010
Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infectionElena Herrera, Solveig Tenckhoff, María J Gómara, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 24, 2007
Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantationJens Rosenau, Nazanin Hooman, Johannes Hadem, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 12, 2006
Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune responseJens Rosenau, Nazanin Hooman, Kinan Rifai, et al.
The American Journal of Gastroenterology|June 28, 2019
Iberogast-Induced Acute Liver Failure-Reexposure and In Vitro Assay Support CausalityFlorian Gerhardt, Andreas Benesic, Hans L Tillmann, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 16, 2024
Trends in mortality from gastrointestinal, hepatic, and pancreatic cancers in the United States: A comprehensive analysis (1999-2020)Hassam Ali, Rizwan Ishtiaq, Brandon Tedder, et al.
Antiviral Therapy|September 9, 2011
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analoguesJerzy Jaroszewicz, Huy Ho, Antoaneta Markova, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Journal of Hepatology|October 16, 2012
IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patientsMelanie E Garrett, Manal F Abdelmalek, Allison Ashley-Koch, et al.
Antiviral Therapy|December 14, 2011
Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patientsKeyur Patel, Seng G Lim, Chow W Cheng, et al.
Gastroenterology|February 24, 2010
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirinJeanette J McCarthy, Josephine H Li, Alexander Thompson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trialHans L Tillmann, Thorsten Kaiser, Zoe Fox, et al.
Journal of Medicinal Chemistry|August 20, 2010
Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infectionElena Herrera, Solveig Tenckhoff, María J Gómara, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 24, 2007
Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantationJens Rosenau, Nazanin Hooman, Johannes Hadem, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 12, 2006
Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune responseJens Rosenau, Nazanin Hooman, Kinan Rifai, et al.
The American Journal of Gastroenterology|June 28, 2019
Iberogast-Induced Acute Liver Failure-Reexposure and In Vitro Assay Support CausalityFlorian Gerhardt, Andreas Benesic, Hans L Tillmann, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 16, 2024
Trends in mortality from gastrointestinal, hepatic, and pancreatic cancers in the United States: A comprehensive analysis (1999-2020)Hassam Ali, Rizwan Ishtiaq, Brandon Tedder, et al.
Antiviral Therapy|September 9, 2011
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analoguesJerzy Jaroszewicz, Huy Ho, Antoaneta Markova, et al.
Pageof 13